DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer

Phase 1

Conditions: Head and Neck Cancer

First Posted Date: 2005-02-08

Last Posted Date: 2013-09-20

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00103155

Locations: 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States

Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer

Phase 2

Conditions: Head and Neck Cancer

First Posted Date: 2004-12-09

Last Posted Date: 2014-01-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 25

Registration Number: NCT00098852

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Ovarian Cancer
Lung Cancer
Neurotoxicity

First Posted Date: 2004-09-06

Last Posted Date: 2012-09-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT00003072

Locations: 🇺🇸
Oncology Service of San Francisco General Hospital Medical Center, San Francisco, California, United States
🇺🇸
UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
🇺🇸
UCSF/Mt. Zion Cancer Center, San Francisco, California, United States

and more 1 locations

Disability and Health Outcomes in COPD

Completed

Conditions: Lung Diseases
Chronic Obstructive Pulmonary Disease

First Posted Date: 2004-07-19

Last Posted Date: 2015-12-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1589

Registration Number: NCT00087906

Maintaining Nonsmoking: Older Smokers - 1

Phase 3

Completed

Conditions: Tobacco Use Disorder

Interventions: Drug: Nicotine polacrilex, Bupropion

First Posted Date: 2004-07-07

Last Posted Date: 2015-03-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 403

Registration Number: NCT00086385

Locations: 🇺🇸
San Francisco, San Francisco, California, United States

Tele-Electrocardiography in Emergency Cardiac Care

Phase 3

Completed

Conditions: Chest Pain
Myocardial Infarction

Interventions: Other: Routine Clinical Practice
Device: Electrocardiogram (ECG) Intervention

First Posted Date: 2004-01-05

Last Posted Date: 2015-06-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 794

Registration Number: NCT00075088

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Kidney and Liver Transplantation in People With HIV

Completed

Conditions: HIV Infections
Kidney Disease
Liver Disease

First Posted Date: 2003-12-15

Last Posted Date: 2014-01-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 275

Registration Number: NCT00074386

Locations: 🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
University of Miami, Jackson Memorial Medical Center, Miami, Florida, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

and more 18 locations

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

Phase 1

Withdrawn

Conditions: Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer

First Posted Date: 2003-11-21

Last Posted Date: 2012-09-14

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00025532

Locations: 🇺🇸
UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

Not Applicable

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

First Posted Date: 2003-10-30

Last Posted Date: 2013-08-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT00071656

Locations: 🇺🇸
HALP Clinic, Children's Center at Langley Porter, UCSF, San Francisco, California, United States

Evaulation of Interaction Between Herbal Products and Anticoagulants

Withdrawn

Conditions: Coagulation Disorders

First Posted Date: 2003-10-30

Last Posted Date: 2013-05-15

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00071682

Locations: 🇺🇸
San Francisco VA Medical Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy